Patents by Inventor Georg Mohr
Georg Mohr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12203107Abstract: A crystal structure of a Non-LTR-retroelement reverse transcriptase and methods of using the same to identify enzymes with improved activity are provided. Mutant reverse transcriptase enzymes and methods of using the same are also provided.Type: GrantFiled: May 10, 2022Date of Patent: January 21, 2025Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Jennifer L. Stamos, Alfred M. Lentzsch, Seung Kuk Park, Georg Mohr, Alan M. Lambowitz
-
Publication number: 20220372453Abstract: A crystal structure of a Non-LTR-retroelement reverse transcriptase and methods of using the same to identify enzymes with improved activity are provided. Mutant reverse transcriptase enzymes and methods of using the same are also provided.Type: ApplicationFiled: May 10, 2022Publication date: November 24, 2022Inventors: Jennifer L. STAMOS, Alfred M. LENTZSCH, Seung Kuk PARK, Georg MOHR, Alan M. LAMBOWITZ
-
Patent number: 11352611Abstract: A crystal structure of a Non-LTR-retroelement reverse transcriptase and methods of using the same to identify enzymes with improved activity are provided. Mutant reverse transcriptase enzymes and methods of using the same are also provided.Type: GrantFiled: October 3, 2018Date of Patent: June 7, 2022Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Jennifer L. Stamos, Alfred M. Lentzsch, Seung Kuk Park, Georg Mohr, Alan M. Lambowitz
-
Patent number: 10858636Abstract: Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse transcriptase. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.Type: GrantFiled: August 1, 2018Date of Patent: December 8, 2020Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Alan M. Lambowitz, Sabine Mohr, Georg Mohr, Eman Ghanem
-
Publication number: 20200344246Abstract: Implementations of the present disclosure involve a system and/or method for identifying and mitigating malicious network threats. Network data associated is retrieved from various sources across a network and analyzed to identify a malicious network threat.Type: ApplicationFiled: July 14, 2020Publication date: October 29, 2020Applicant: Level 3 Communications, LLCInventors: Brad Doctor, Skyler Jameson Bingham, Keshava Berg, John Sherwood Reynolds, II, Justin George Mohr
-
Publication number: 20200255810Abstract: A crystal structure of a Non-LTR-retroelement reverse transcriptase and methods of using the same to identify enzymes with improved activity are provided. Mutant reverse transcriptase enzymes and methods of using the same are also provided.Type: ApplicationFiled: October 3, 2018Publication date: August 13, 2020Inventors: Jennifer L. STAMOS, Alfred M. LENTZSCH, Seung Kuk PARK, Georg MOHR, Alan M. LAMBOWITZ
-
Patent number: 10721243Abstract: Implementations of the present disclosure involve a system and/or method for identifying and mitigating malicious network threats. Network data associated is retrieved from various sources across a network and analyzed to identify a malicious network threat. When a threat is found, the system performs a mitigating action to neutralize the malicious network threat.Type: GrantFiled: November 13, 2018Date of Patent: July 21, 2020Assignee: Level 3 Communications, LLCInventors: Brad Bernay Doctor, Skyler Jameson Bingham, Keshava Berg, John Sherwood Reynolds, II, Justin George Mohr
-
Publication number: 20190104136Abstract: Implementations of the present disclosure involve a system and/or method for identifying and mitigating malicious network threats. Network data associated is retrieved from various sources across a network and analyzed to identify a malicious network threat.Type: ApplicationFiled: November 13, 2018Publication date: April 4, 2019Inventors: Brad Bernay Doctor, Skyler Jameson Bingham, Keshava Berg, John Sherwood Reynolds, Justin George Mohr
-
Patent number: 10150955Abstract: Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse temperature. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.Type: GrantFiled: May 25, 2016Date of Patent: December 11, 2018Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Alan M. Lambowitz, Sabine Mohr, Georg Mohr, Eman Ghanem
-
Publication number: 20180346890Abstract: Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse transcriptase. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.Type: ApplicationFiled: August 1, 2018Publication date: December 6, 2018Inventors: Alan M. Lambowitz, Sabine Mohr, Georg Mohr, Eman Ghanem
-
Publication number: 20180340158Abstract: Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse transcriptase. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.Type: ApplicationFiled: August 1, 2018Publication date: November 29, 2018Inventors: Alan M. Lambowitz, Sabine Mohr, Georg Mohr, Eman Ghanem
-
Patent number: 10129270Abstract: Implementations of the present disclosure involve a system and/or method for identifying and mitigating malicious network threats. Network data associated is retrieved from various sources across a network and analyzed to identify a malicious network threat. When a threat is found, the system performs a mitigating action to neutralize the malicious network threat.Type: GrantFiled: September 27, 2013Date of Patent: November 13, 2018Assignee: Level 3 Communications, LLCInventors: Brad Bernay Doctor, Skyler Jameson Bingham, Keshava Berg, John Sherwood Reynolds, II, Justin George Mohr
-
Patent number: 10113156Abstract: Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse transcriptase. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.Type: GrantFiled: March 4, 2010Date of Patent: October 30, 2018Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Alan M. Lambowitz, Sabine Mohr, Georg Mohr, Eman Ghanem
-
Publication number: 20170275665Abstract: The present disclosure provides methods and compositions for the integration of a target RNA or DNA into a DNA substrate. Also provided are methods of forming RNA-DNA bonds and enzymes for performing the same.Type: ApplicationFiled: February 23, 2017Publication date: September 28, 2017Inventors: Sukrit SILAS, Georg MOHR, Devaki BHAYA, Alan M. LAMBOWITZ, Andrew FIRE
-
Publication number: 20160289652Abstract: Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse temperature. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.Type: ApplicationFiled: May 25, 2016Publication date: October 6, 2016Inventors: Alan M. Lambowitz, Sabine Mohr, Georg Mohr, Eman Ghanem
-
Publication number: 20140096251Abstract: Implementations of the present disclosure involve a system and/or method for identifying and mitigating malicious network threats. Network data associated is retrieved from various sources across a network and analyzed to identify a malicious network threat.Type: ApplicationFiled: September 27, 2013Publication date: April 3, 2014Applicant: Level 3 Communications, LLCInventors: Brad Bernay Doctor, Skyler Jameson Bingham, Keshava Berg, John Sherwood Reynolds, II, Justin George Mohr
-
Publication number: 20120009630Abstract: Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse transcriptase. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.Type: ApplicationFiled: March 4, 2010Publication date: January 12, 2012Applicant: Board of Regents, The University of Texas SystemInventors: Alan M. Lambowitz, Sabine Mohr, Georg Mohr, Eman Ghanem
-
Publication number: 20020086323Abstract: Methods, employing a nucleotide integrase, for cleaving single-stranded RNA substrates, single-stranded DNA substrates, and double-stranded DNA substrates at specific sites and for inserting a nucleic acid molecule into the cleaved substrate are provided. One method uses a nucleotide integrase to cleave one strand of a double-stranded DNA substrate. The method comprises the steps of: providing an isolated nucleotide integrase comprising a group II intron RNA having two hybridizing sequences for hybridizing with two intron RNA binding sequences on the top strand of the DNA substrate, and a group I-intron encoded protein which binds to a first sequence element of the substrate; and reacting the nucleotide integrase with the double-stranded DNA substrate to permit the nucleotide integrase to cleave the top strand of the DNA substrate and to insert the group II intron RNA into the cleavage site.Type: ApplicationFiled: October 22, 2001Publication date: July 4, 2002Inventors: Alan M. Lambowitz, Steven Zimmerly, Huatao Guo, Georg Mohr, Clifford James Beall
-
Patent number: 6306596Abstract: Methods, employing a nucleotide integrase, for cleaving single-stranded RNA substrates, single-stranded DNA substrates, and double-stranded DNA substrates at specific sites and for inserting a nucleic acid molecule into the cleaved substrate are provided. One method uses a nucleotide integrase to cleave one strand of a double-stranded DNA substrate. The method comprises the steps of: providing an isolated nucleotide integrase comprising a group II intron RNA having two hybridizing sequences for hybridizing with two intron RNA binding sequences on the top strand of the DNA substrate, and a group II-intron encoded protein which binds to a first sequence element of the substrate; and reacting the nucleotide integrase with the double-stranded DNA substrate to permit the nucleotide integrase to cleave the top strand of the DNA substrate and to insert the group II intron RNA into the cleavage site.Type: GrantFiled: February 25, 1999Date of Patent: October 23, 2001Assignee: The Ohio State University Research FoundationInventors: Allen M. Lambowitz, Steven Zimmerly, Huatao Guo, Georg Mohr, Clifford James Beall
-
Patent number: 6027895Abstract: The present invention provides new methods, employing a nucleotide integrase, for cleaving single-stranded RNA substrates, single-stranded DNA substrates, and double- stranded DNA substrates at specific sites and for inserting a nucleic acid molecule into the cleaved substrate. One method uses a nucleotide integrase to cleave one strand of a double-stranded DNA substrate. The method comprises the steps of: providing a nucleotide integrase comprising a group II intron RNA having two hybridizing sequences that are capable of hybridizing with two intron RNA binding sequences on the one strand of the DNA substrate, and a group II-intron encoded protein which binds to a first sequence element of the substrate; and reacting the nucleotide integrase with the double-stranded DNA substrate under conditions that permit the nucleotide integrase to cleave the one strand of the DNA substrate and to insert the group II intron RNA into the cleavage site.Type: GrantFiled: February 27, 1998Date of Patent: February 22, 2000Assignee: The Ohio State University Research FoundationInventors: Allen M. Lambowitz, Steven Zimmerly, Huatao Gau, Georg Mohr, Clifford James Beall